About us

The Australian Dementia Network (ADNeT) is the largest single research program funded to date through the NHMRC’s $200 million Boosting Dementia Research Initiative, with $2 million additional support from philanthropic organisations the Wicking Trust and the Yulgilbar Foundation.

ADNeT brings together the country’s top researchers to create a sustainable, translational research infrastructure to drive ongoing, high quality research and clinical care for Australians living with, or at risk of, cognitive impairment and dementia.

Dementia is Australia’s second leading cause of death. Without a medical breakthrough, the number of Australians with a diagnosis of dementia is expected to increase to over 530,000 by 2025 and over 1.1 million by 2056.  Other challenges to the sector include service fragmentation and the lack of unified standards to improve dementia diagnosis and care in the Australian context.

To address the problem, ADNeT brings together Australia’s leading researchers and stakeholders to:

  • Establish an integrated network of dementia researchers, clinicians, service providers, industry, and consumers to drive this priority national translational research initiative
  • Develop and maintain a clinical quality registry (CQR) that can track, benchmark and report on the quality of clinical care of people with dementia and mild cognitive impairment to drive quality improvement, identify suitable and willing persons for clinical trials, and systematically collect longitudinal data for research on the determinants, epidemiology and trajectory of cognitive decline
  • Establish a national network of Memory Clinics to optimise the assessment of cognitive disorders and improve specialist access for all Australians
  • Develop a large, highly-characterised cohort of people with dementia, or at increased risk of dementia, to populate a Trials-Ready Cohort for participation in cutting-edge clinical trials and to study the natural history of dementia
  • Connect with existing infrastructure supporting clinical trials in Australia to enhance the capacity for state-of-the-art assessments and the conduct of clinical trials nationwide
  • Integrate Australian research with the international effort to prevent or effectively treat dementia

ADNeT committee members meet in Melbourne on Wednesday, May 8, 2019.

ADNeT brings together the country’s top researchers to create a sustainable, translational research infrastructure to drive ongoing, high quality research and clinical care for Australians living with, or at risk of, cognitive impairment and dementia.

Led by Professor Chris Rowe, ADNeT is comprised of 25 investigators, 12 institutions and a broad spectrum of government, clinicians and consumer advisors.

ADNeT is supported by the NMRC National Institute for Dementia Research, the Wicking Trust, Yugilbar Foundation, Dementia Australia and Austin Health.

Partner institutions are drawn from across Australia, including the University of Melbourne, University of New South Wales, Monash University, Edith Cowan University, CSIRO,  Flinders University, SAHMRI, University of  Sydney, NeuRA, Macquarie University,  QIMR Berghofer, and the University of Tasmania.